Xiaofang Xu

1.2k citations
39 papers · 883 indexed · h-index 18
Topics
Ocular Oncology and Treatments (9 papers)Glaucoma and retinal disorders (5 papers)Retinal Diseases and Treatments (3 papers)
Journals
NatureCirculationSHILAP Revista de lepidopterología
Partner nations
ChinaUnited States

In The Last Decade

Xiaofang Xu

36 papers receiving 871 citations

Peers

Xiaofang Xu
Comparison fields: 5 of 109
  • Molecular Biology 501
  • Cancer Research 203
  • Ophthalmology 158
  • Surgery 123
  • Oncology 121
Replace Adam L. Green with:
Adam L. Green United States
Shiuh‐Wen Luoh United States
Peter E. Hall United Kingdom
Andrea Murray United Kingdom
Zhe Sun China
Heidi L. Miller United States
Lifeng Tian China
Justin Chen United States
Ahmad Al‐Moujahed United States
Michela Borghesan United Kingdom
Xiaofang Xu relative to Adam L. Green United States Adam L. Green's profile →
Citations per field
00.5×3.1×
Adam L. Green · 1×
Citations per year

Countries citing papers authored by Xiaofang Xu

Since Specialization
Citations

This map shows the geographic impact of Xiaofang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofang Xu more than expected).

Fields of papers citing papers by Xiaofang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofang Xu. The network helps show where Xiaofang Xu may publish in the future.

Co-authorship network of co-authors of Xiaofang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofang Xu. A scholar is included among the top collaborators of Xiaofang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofang Xu. Xiaofang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 7
5 2
6 1
7 4
8 0
9 16
10 27
11 10
12 108
13 48
14 8
15 39
16 4
17 8
18 119
19 13
20 19

About Xiaofang Xu

Xiaofang Xu is a scholar working on Ophthalmology, Horticulture and Cancer Research, having authored 39 papers that have together received 883 indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (9 papers), Glaucoma and retinal disorders (5 papers) and Retinal Diseases and Treatments (3 papers). The work is most often cited by research in Ophthalmology (158 citations), Cancer Research (203 citations) and Molecular Biology (501 citations). Xiaofang Xu has collaborated with scholars based in China and United States. Frequent co-authors include Jon S. Odorico, Victoria L. Browning, Shengfang Ge, Xianqun Fan, Renbing Jia, Yixiong Zhou, Qin Xu, Zhi Hua Ran, Shengen Xiao and Mingming Zhu. Their work appears in journals such as Nature, Circulation and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026